Comparing clinical outcomes of piperacillin-tazobactam administration and dosage strategies in critically ill adult patients: a systematic review and meta-analysis.

BMC Infect Dis · 2020 · PMC7305614 · PMID 32563242

Europe PMC DOI

hedged sentence

0.5300

closest p · 10.6× alpha

0.5300

boldest claim

The sentences

did not reach statistical significanceP = 0.53not close (p > 0.1)

C/PI resulted in a lower percentage of adverse events however, the difference between the two groups did not reach statistical significance (935 patients; OR 0.85, 95% C.I 0.50–1.42, P = 0.53; Fig. 8 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.